Sv7 Impact Medicine Fund Lp Xilio Therapeutics, Inc. (XLO) insider trading activity
Sv7 Impact Medicine Fund LP is > 10% Shareholder of Xilio Therapeutics, Inc.. Currently has a direct ownership of 1.3 Million shares of XLO, which is worth approximately $1.72 Million. The most recent transaction as insider was on Oct 26, 2021, when has been sold 1,301,132 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.3M
0%
3M change
0%
12M change
Total Value Held
$1.72 Million
SIM
Sv7 Impact Medicine Fund LP
> 10% Shareholder
London, X0